Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Research Area(s) / Expertise: Job title: Professor of Cardiology, Head of ICCU
Dr Ovidiu Chioncel is Professor of Cardiology and Head of ICCU at theUniversity of Medicine Carol Davila in Bucharest, Romania. His clinical research interests include heart failure, cardiac imaging and emergency medicine. Dr Chioncel has been involved in numerous clinical trials, and is Director of the Romanian Acute Heart Failure Syndrome registry (RO-AHFS), the National Registry of Acute… View more
Job title: Cardiologist
Dr Andrew Sindone, is a Cardiologist and Director, Heart Failure Unit and Department of Cardiac Rehabilitation at theConcord Hospital, Sydney, AU. His research interests include heart failure, hypertension, cardiac function, cardiomyopathies and acute heart failure. View more
Added: 3 years ago
Dr Gad Cotter (Momentum Research, Durham, NC, US) and Dr Beth Davison (Momentum Research, Durham, NC, US) discuss an analysis of BIOSTAT-CHF to determine Acute Heart Failure as a distinctive disorder. Questions: 1. Can you briefly remind us of BIOSTAT-CHF? 2. What was the rationale for this analysis? 3. What was the design of this analysis? 4. What were the end-points? Were they met? 5. What… View more
Research Area(s) / Expertise: Job title: Head of the Cardiology Department
Dr Antoni Bayés-Genís is Professor of Cardiology at the Universitat Autònoma de Barcelona, Spain and Head of the Cardiology Department at the University Hospital Germans Trias i Pujol, Barcelona. Dr Bayés-Genís is also an expert on biomarker, including natriuretic peptides ST2 and neprilysin, having lectured on the subject at numerous international meetings and generated research data that… View more
Research Area(s) / Expertise: Job title: Assistant Professor, Advanced Heart Failure & Transplantation
Dr Stephen Greene is Assistant Professor in Advanced Heart Failure & Transplantation atThe Duke University School of Medicine inDurham, North Carolina, US. Dr Greene isa cardiologist with a clinical and research interest in heart failure. Hisresearch interests are focused on strategies and therapies to improve outcomes and quality of life for patients with heart failure. This involves research… View more
Author(s): Barry Borlaug Added: 1 year ago
ACC.23/WCC —In this short interview from the ACC's 2023 Scientific Sessions, Dr Barry Borlaug (Mayo Clinic, US) joins us virtually to discuss a trial which aims to evaluate the mechanism of benefit for dapagliflozin in patients with heart failure with preserved ejection fraction (Mayo Clinic). The study was conducted over 6 months with 43 patients enrolled in the trial. The main findings suggest… View more
Author(s): Zoltán Papp , Piergiuseppe Agostoni , Julian Alvarez , et al Added: 3 years ago
Origins of a Unique Cardiovascular Agent Before the 1980s, therapy to enhance cardiac contractility in heart failure (HF) substantially meant oral digitalis glycosides, supplemented by beta-adrenergic agonists such as dopamine or dobutamine (introduced in the middle of the 1970s) in acute situations.1 It was therefore a matter of some note when the US Food and Drug Administration approved a new… View more
Start date: Oct 17, 2023
Foreword

Article

Author(s): Andrew JS Coats , Giuseppe Rosano Added: 3 years ago
We have great pleasure in introducing the latest issue of Cardiac Failure Review. As we gear up for the annual heart failure congress of the European Heart Failure Association (29 April–2 May 2017), we reflect on the successes and failures since the influential European guidelines were published in Florence a year ago. In this 12-month period we have seen the promotion of a new category of… View more